Literature DB >> 18061382

Antioxidant and mitochondrial protective effects of silibinin in cold preservation-warm reperfusion liver injury.

H Ligeret1, A Brault, D Vallerand, Y Haddad, P S Haddad.   

Abstract

AIM OF THE STUDY: Silybum marianum (milk thistle) is a Mediterranean plant that has been used since Greco-Roman times to treat liver ailments. Silibinin, the most active hepatoprotective constituent of the plant's seed, possesses antioxidant and anti-inflammatory properties. We thus assessed its protective potential in liver transplantation injury.
MATERIALS AND METHODS: Rat livers were isolated and preserved during 24h at 4 degrees C in University of Wisconsin (UW) solution alone (control), UW containing 100 microM silibinin or UW containing vehicle (ethanol). Livers were then reperfused at 37 degrees C for 1h with Krebs-Henseleit solution supplemented with 20% erythrocytes.
RESULTS: Compared to control, cold preservation and warm reperfusion promoted lipid peroxidation (+40%) and superoxide anion generation (+147%), while attenuating reduced glutathione (-23%), mitochondrial ATP content (-57%) and respiratory control ratio (RCR; -37%). Preservation done in presence of silibinin improved parameters affected by preservation and reperfusion. In fact, silibinin promoted an increase of ATP and RCR by, respectively, 39 and 16% and decreased oxidative stress to values observed in livers never preserved nor perfused.
CONCLUSIONS: In conclusion, silibinin shows promise in protecting the liver from cold preservation/warm reperfusion damages. Moreover our study suggests that concepts of traditional medicine have the potential to be transposed successfully in the context of modern medical interventions such as liver transplantation surgery.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18061382     DOI: 10.1016/j.jep.2007.10.024

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  21 in total

Review 1.  Silybin and the liver: from basic research to clinical practice.

Authors:  Carmela Loguercio; Davide Festi
Journal:  World J Gastroenterol       Date:  2011-05-14       Impact factor: 5.742

2.  Ursodeoxycholyl lysophosphatidylethanolamide inhibits cholestasis- and hypoxia-induced apoptosis by upregulating antiapoptosis proteins.

Authors:  Myra Sellinger; Weihong Xu; Anita Pathil; Wolfgang Stremmel; Walee Chamulitrat
Journal:  Exp Biol Med (Maywood)       Date:  2014-08-14

3.  Silibinin attenuates methotrexate-induced pulmonary injury by targeting oxidative stress.

Authors:  Serdar Kalemci; Yasar Topal; Serkan Yasar Celik; Nigar Yilmaz; Halil Beydilli; Mehmet Ilkay Kosar; Nigar Dirican; Irfan Altuntas
Journal:  Exp Ther Med       Date:  2015-06-03       Impact factor: 2.447

Review 4.  Review of natural products with hepatoprotective effects.

Authors:  Eduardo Madrigal-Santillán; Eduardo Madrigal-Bujaidar; Isela Álvarez-González; María Teresa Sumaya-Martínez; José Gutiérrez-Salinas; Mirandeli Bautista; Ángel Morales-González; Manuel García-Luna y González-Rubio; J Leopoldo Aguilar-Faisal; José A Morales-González
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

Review 5.  Molecular mechanisms of silibinin-mediated cancer chemoprevention with major emphasis on prostate cancer.

Authors:  Harold Ting; Gagan Deep; Rajesh Agarwal
Journal:  AAPS J       Date:  2013-04-16       Impact factor: 4.009

6.  Silibinin ameliorates arsenic induced nephrotoxicity by abrogation of oxidative stress, inflammation and apoptosis in rats.

Authors:  S Milton Prabu; M Muthumani
Journal:  Mol Biol Rep       Date:  2012-10-16       Impact factor: 2.316

7.  Molecular and biochemical evidence on the protective role of ellagic acid and silybin against oxidative stress-induced cellular aging.

Authors:  Maryam Baeeri; Solmaz Mohammadi-Nejad; Mahban Rahimifard; Mona Navaei-Nigjeh; Shermineh Moeini-Nodeh; Reza Khorasani; Mohammad Abdollahi
Journal:  Mol Cell Biochem       Date:  2017-09-08       Impact factor: 3.396

8.  Silymarin suppresses hepatic stellate cell activation in a dietary rat model of non-alcoholic steatohepatitis: analysis of isolated hepatic stellate cells.

Authors:  Mina Kim; Su-Geun Yang; Joon Mi Kim; Jin-Woo Lee; Young Soo Kim; Jung Il Lee
Journal:  Int J Mol Med       Date:  2012-06-14       Impact factor: 4.101

9.  NCX 1000 Alone or in Combination with Vitamin E Reverses Experimental Nonalcoholic Steatohepatitis in the Rat Similarly to UDCA.

Authors:  Yara Haddad; Diane Vallerand; Antoine Brault; Jean Spénard; Pierre S Haddad
Journal:  Int J Hepatol       Date:  2011-10-16

10.  Larix laricina, an Antidiabetic Alternative Treatment from the Cree of Northern Quebec Pharmacopoeia, Decreases Glycemia and Improves Insulin Sensitivity In Vivo.

Authors:  Despina Harbilas; Diane Vallerand; Antoine Brault; Ammar Saleem; John T Arnason; Lina Musallam; Pierre S Haddad
Journal:  Evid Based Complement Alternat Med       Date:  2012-07-19       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.